Download
Koelman-et-al_2020_Effects of High and Low Protein Diets on Inflammatory Profiles in People with Morbid Obesity_A 3-Week Intervention Study.pdf 1,09MB
WeightNameValue
1000 Titel
  • Effects of High and Low Protein Diets on Inflammatory Profiles in People with Morbid Obesity: A 3-Week Intervention Study
1000 Autor/in
  1. Koelman, Liselot |
  2. Markova, Mariya |
  3. Seebeck, Nicole |
  4. Hornemann, Silke |
  5. Rosenthal, Anke |
  6. Lange, Volker |
  7. Ramich (Pivovarova), Olga |
  8. Aleksandrova, Krasimira |
1000 Erscheinungsjahr 2020
1000 LeibnizOpen
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-11-26
1000 Erschienen in
1000 Quellenangabe
  • 12(12):3636
1000 FRL-Sammlung
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.3390/nu12123636 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759799/ |
1000 Ergänzendes Material
  • https://www.mdpi.com/2072-6643/12/12/3636#supplementary |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Nutritional interventions in morbidly obese individuals that effectively reverse a pro-inflammatory state and prevent obesity-associated medical complications are highly warranted. Our aim was to evaluate the effect of high (HP) or low (LP) protein diets on circulating immune-inflammatory biomarkers, including C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-a), interleukin-10 (IL-10), monocyte chemoattractant protein-1 (MCP-1), chemerin, omentin, leptin, total adiponectin, high molecular weight adiponectin, and fetuin-A. With this aim, 18 people with morbid obesity were matched into two hypocaloric groups: HP (30E% protein, n = 8) and LP (10E% protein, n = 10) for three weeks. Biomarkers were measured pre and post intervention and linear mixed-effects models were used to investigate differences. Consuming HP or LP diets resulted in reduced CRP (HP: −2.2 ± 1.0 mg/L, LP: −2.3 ± 0.9 mg/L) and chemerin (HP: −17.9 ± 8.6 ng/mL, LP: −20.0 ± 7.4 ng/mL), with no statistically significant differences by diet arm. Participants following the LP diet showed a more pronounced decrease in leptin (−19.2 ± 6.0 ng/mL) and IL-6 (−0.4 ± 0.1 pg/mL) and an increase in total adiponectin (1.6 ± 0.6 µg/mL). Changes were also observed for the remaining biomarkers to a smaller degree by the HP than the LP hypocaloric diet, suggesting that a LP hypocaloric diet modulates a wider range of immune inflammatory biomarkers in morbidly obese individuals.
1000 Sacherschließung
lokal Nutritional intervention
lokal Low protein
lokal Inflammatory biomarkers
lokal Morbid obesity
lokal High protein
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/S29lbG1hbiwgTGlzZWxvdA==|https://frl.publisso.de/adhoc/uri/TWFya292YSwgTWFyaXlh|https://frl.publisso.de/adhoc/uri/U2VlYmVjaywgTmljb2xl|https://frl.publisso.de/adhoc/uri/SG9ybmVtYW5uLCBTaWxrZQ==|https://frl.publisso.de/adhoc/uri/Um9zZW50aGFsLCBBbmtl|https://frl.publisso.de/adhoc/uri/TGFuZ2UsIFZvbGtlcg==|https://orcid.org/0000-0002-3583-8546|https://orcid.org/0000-0002-1275-1827
1000 Label
1000 Förderer
  1. European Association for the Study of Diabetes |
  2. Deutsches Zentrum für Diabetesforschung |
1000 Fördernummer
  1. Identification of individual response criteria for reduction of hepatic fat by nutritional approaches and subsequent maintenance by dietary strategies
  2. Is FGF21 as novel bidirectional regulator of protein preference and aversion: regulatory mechanisms and clinical implications; Role of Wnt-inducible signaling pathway protein-1 (WISP-1) in adipose tissue and liver fibrosis in mice and men
1000 Förderprogramm
  1. -
  2. -
1000 Dateien
  1. Effects of High and Low Protein Diets on Inflammatory Profiles in People with Morbid Obesity_A 3-Week Intervention Study
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer European Association for the Study of Diabetes |
    1000 Förderprogramm -
    1000 Fördernummer Identification of individual response criteria for reduction of hepatic fat by nutritional approaches and subsequent maintenance by dietary strategies
  2. 1000 joinedFunding-child
    1000 Förderer Deutsches Zentrum für Diabetesforschung |
    1000 Förderprogramm -
    1000 Fördernummer Is FGF21 as novel bidirectional regulator of protein preference and aversion: regulatory mechanisms and clinical implications; Role of Wnt-inducible signaling pathway protein-1 (WISP-1) in adipose tissue and liver fibrosis in mice and men
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6426261.rdf
1000 Erstellt am 2021-03-18T12:39:22.238+0100
1000 Erstellt von 266
1000 beschreibt frl:6426261
1000 Bearbeitet von 122
1000 Zuletzt bearbeitet Tue Mar 23 08:59:50 CET 2021
1000 Objekt bearb. Tue Mar 23 08:59:37 CET 2021
1000 Vgl. frl:6426261
1000 Oai Id
  1. oai:frl.publisso.de:frl:6426261 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source